Synthesis of fluorinated pyrrolo[2,3-b]pyridine and pyrrolo[2,3-d] pyrimidine nucleosides

Synthesis

Volumn , Issue 11, 2009, Pages 1851-1857

  Iaroshenko, Viktor O ^a,b   Wang, Yan ^c   Sevenard, Dmitri V ^d   Volochnyuk, Dmitriy M ^a,e  

^a ENAMINE LTD   (Ukraine)

^b TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

^c UNIVERSITY OF KONSTANZ   (Germany)

^d UNIVERSITY OF BREMEN   (Germany)

^e INSTITUTE OF ORGANIC CHEMISTRY   (Ukraine)

Author keywords

Amine; Annulation; Electrophilic aromatic substitution; Fluorine; Pyridine; Pyrrole

Indexed keywords

ADENOSINE DEAMINASE; ANNULATION; ELECTROPHILIC AROMATIC SUBSTITUTION; INOSINE; MONOPHOSPHATE; PROTECTING GROUP; PYRIMIDINE NUCLEOSIDES; PYRROLE;

AMINES; AROMATIC COMPOUNDS; FLUORINE; NITROGEN COMPOUNDS; SULFURIC ACID; SYNTHESIS (CHEMICAL);

PYRIDINE;

ADENOSINE DEAMINASE INHIBITOR; COFORMYCIN; ELECTROPHILE; INOSINATE DEHYDROGENASE INHIBITOR; PENTOSTATIN; PYRROLO[2,3 B]PYRIDINE DERIVATIVE; PYRROLO[2,3 B]PYRIMIDINE DERIVATIVE; PYRROLOPYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANNULATION REACTION; ARTICLE; CHEMICAL REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; FLUORINATION; GLYCOSYLATION; REACTION ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 67650047678     PISSN: 00397881     EISSN: 1437210X     Source Type: Journal    
DOI: 10.1055/s-0029-1216640     Document Type: Article

References (54)

1. (a) Ugarkar, B. G.; DaRe, J. M.; Kopcho, J. J.; Browne, C. E. III; Schanzer, J. M.; Wiesner, J. B.; Erion, M. D. J. Med. Chem. 2000, 43, 2883.
2. (b) Erion, M. D.; Ugarkar, B. G.; DaRe, J. M.; Castellino, A. J.; Fujitaki, J. M.; Dixon, R.; Appleman, J. R.; Wiesner, J. B. Nucleosides, Nucleotides Nucleic Acids 1997, 16, 1013.
3. (a) Seela, F.; Zulauf, M. Nucleosides, Nucleotides Nucleic Acids 1999, 18, 2697.
4. (b) Renau, T. E.; Kennedy, C.; Ptak, R. G.; Breitenbach, J. M.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 1996, 39, 3470.
5. (c) Crawczyk, S. H.; Renau, T. E.; Nassiri, M. R.; Westerman, A. C.; Wotring, L. L.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 1995, 38, 4115.
6. (d) Crawczyk, S. H.; Nassiri, M. R.; Kucera, L. S.; Kern, E. R.; Ptak, R. G.; Wotring, L. L.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 1995, 38, 4106.
7. (a) Nekhai1, S.; Bhat, U. G.; Ammosova1, T.; Radhakrishnan, S. K.; Jerebtsova, M.; Niu, X.; Foster, A.; Layden, T. J.; Gartel, A. L. Oncogene 2007, 26, 3899.
8. (b) Mohapatra, S.; Pledger, W. J. US 2007,238,745, 2007; Chem. Abstr. 2007, 147, 420059.
9. (c) Fujiwara, Y.; Hosokawa, Y.; Watanabe, K.; Tanimura, S.; Ozaki, K.-I.; Kohno, M. Mol. Cancer Ther. 2007, 6, 1133.
10. (a) Porcari, A. R.; Ptak, R. G.; Borysko, K. Z.; Breitenbach, J. M.; Drach, J. C.; Townsend, L. J. Med. Chem. 2000, 43, 2457.
11. (b) Gartel, A. L.; Radhakrishnan, S. K. WO 2006,116,512, 2006; Chem. Abstr. 2006, 145, 465765.
12. (c) Gordon, R. K.; Ginalski, K.; Rudnicki, W. R.; Rychlewski, L.; Pankaskie, M. C.; Bujnicki, J. M.; Chiang, P. K. Eur. J. Biochem. 2003, 270, 3507.
13. (a) Mekouar, K.; Deziel, R.; Mounir, S.; Iyer, R. P. WO 03,055,896, 2003; Chem. Abstr. 2003, 139, 53249.
14. (b) Schul, W.; Liu, W.; Xu, H.-Y.; Flamand, M.; Vasudevan, S. G. J. Infect. Dis. 2007, 195, 665.
15. (c) Maccoss, M.; Olsen, D. B.; Leone, J.; Durette, P. L. WO 2006,065,335, 2006; Chem. Abstr. 2006, 145, 76603.
16. (d) Maccoss, M.; Olsen, D. B. WO 2006,012,078, 2006; Chem. Abstr. 2006, 144, 192451.
17. (a) Hoffman, K.; Holmes, F. A.; Fraschini, G.; Esparza, L.; Frye, D.; Raber, M. N.; Newman, R. A.; Hortobagyi, G. N. Cancer Chemother. Pharmacol. 1996, 37, 254.
18. (b) O'Connell, M. J.; Rubin, J.; Hahn, R. G.; Kvols, L. K.; Moertel, C. G. Cancer Treat. Rep. 1987, 71, 333.
19. (c) Lyss, A. P.; Morrell, L. E.; Perry, M. C. Proc. Am. Soc. Clin. Oncol. 1991, 10, 120.
20. (d) Feun, L. G.; Blessing, J. A.; Barrett, R. J.; Hanjani, P. A. Am. J. Clin. Oncol. 1993, 16, 506.
21. Mantovanini, M.; Melillo, G.; Daffonchio, L. WO 9,504,742, 1995; Chem. Abstr. 1995, 122, 314537.
22. Easterwood, L. M.; Veliz, E. A.; Beal, P. A. J. Am. Chem. Soc. 2000, 122, 11537.
23. Veliz, E. A.; Easterwood, L. M.; Beal, P. A. J. Am. Chem. Soc. 2003, 125, 10867.
24. Cristalli, G.; Eleuteri, A.; Vittori, S.; Volpini, R.; Camaioni, E.; Lupidi, G. Drug Dev. Res. 1993, 28, 253.
25. (a) Lupidi, G.; Marmocchi, F.; Cristalli, G. Biochem. Mol. Biol. 1998, 46, 1071.
26. (b) Lupidi, G.; Cristalli, G.; Marmocchi, F.; Riva, F.; Grifantini, M. J. Enzyme Inhib. Med. Chem. 1985, 1, 67.
27. (c) Okamoto, A.; Tanaka, K.; Saito, I. Bioorg. Med. Chem. Lett. 2002, 12, 97.
28. Erion, M. D.; Reddy, M. R. J. Am. Chem. Soc. 1998, 120, 3295.
29. (a) Begue, J.-P.; Bonnet-Delpon, D. Chemie Bioorganique et Medicinal du Fluor; EDP Sciences: Paris, 2005, 366.
30. (b) Silverman, R. B. The Organic Chemistry of Drug Design and Drug Action, 2nd Ed.; Elsevier Academic Press: Amsterdam, 2004, 617.
31. Agarwal, R. P.; Spector, T.; Parks, R. E. Biochem. Pharmacol. 1977, 26, 359.
32. (a) Iaroshenko, V. O.; Volochnyuk, D. M.; Wang, Y.; Vovk, M. V.; Boiko, V. J.; Rusanov, E. B.; Groth, U. M.; Tolmachev, A. O. Synthesis 2007, 3309.
33. (b) Iaroshenko, V. O.; Groth, U.; Kryvokhyzha, N. V.; Obeid, S.; Tolmachev, A. A.; Wesch, T. Synlett 2008, 343.
34. (c) Volochnyuk, D. M.; Pushechnikov, A. O.; Krotko, D. G.; Sibgatulin, D. A.; Kovalyova, S. A.; Tolmachev, A. A. Synthesis 2003, 1531.
35. (d) Vovk, M. V.; Bolbut, A. V.; Boiko, V. I.; Pirozhenko, V. V.; Chernega, A. N.; Tolmachev, A. A. Chem. Heterocycl. Compd. (Engl. Transl.) 2004, 40, 370.
36. (e) Vovk, M. V.; Bol'but, A. V.; Dorokhov, V. I.; Pyrozhenko, V. V. Synth. Commun. 2002, 32, 3749.
37. (f) Iaroshenko, V. O.; Volochnyuk, D. M.; Kryvokhyzha, N. V.; Martyloga, A.; Sevenard, D. V.; Groth, U.; Brand, J.; Chernega, A. N.; Shivanyuk, A. N.; Tolmachev, A. A. Synthesis 2008, 2337.
38. De Rosa, M.; Issac, R. P.; Houghton, G. Tetrahedron Lett. 1995, 36, 9261.
39. Allegretti, M.; Anacardio, R.; Cesta, M. C.; Curti, R.; Mantovanini, M.; Nano, G.; Topai, A.; Zampella, Gi. Org. Process Res. Dev. 2003, 7, 209.
40. (a) Brodrick, A.; Wibberley, D. G. J. Chem. Soc., Perkin Trans. 1 1975, 1910.
41. (b) Benoit, R.; Dupas, G.; Bourguignon, J.; Queguiner, G. Synthesis 1987, 1124.
42. (a) Zanatta, N.; Amaral, S. S.; Esteves-Souza, A.; Echevarria, A.; Brondani, P. B.; Flores, D. C.; Bonacorso, H. G.; Flores, A. F. C.; Martins, M. A. P. Synthesis 2006, 2305.
43. (b) Kondratov, I. S.; Gerus, I. I.; Kacharov, A. D.; Gorbunova, M. G.; Kukhar, V. P.; Froehlich, R. J. Fluorine Chem. 2005, 126, 543.
44. (c) Matsumoto, N.; Takahashi, M. Tetrahedron Lett. 2005, 46, 5551.
45. (a) Dang, Q.; Brown, B. S.; Erion, M. D. J. Org. Chem. 1996, 61, 5204.
46. (b) Dang, Q.; Gomez-Galeno, J. E. J. Org. Chem. 2002, 67, 8703.
47. (c) Dang, Q.; Liu, Y.; Erion, M. D. J. Am. Chem. Soc. 1999, 121, 5833.
48. Vorbruggen, H.; Ruh-Pohlenz, C. Handbook of Nucleoside Synthesis; John Wiley & Sons: Chichester, 2001.
49. (a) Reid, J. C.; Calvin, M. J. Am. Chem. Soc. 1950, 72, 2948.
50. (b) Park, J. D.; Brown, H. A.; Lacher, J. R. J. Am. Chem. Soc. 1953, 75, 4753.
51. (c) Pashkevich, K. I.; Khomutov, O. G.; Sevenard, D. V. Russ. J. Org. Chem. 1998, 34, 1727;
52. Zh. Org. Khim. 1998, 34, 1798.
53. (d) Sevenard, D. V.; Lork, E. J. Fluorine Chem. 2004, 125, 125.
54. Crystallographic data (excluding structure factors) for the structures reported in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC 703680 and CCDC 683574 can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: +44(1223)336033; e-mail: deposit@ccdc.cam.ac.uk.